Sports Analytics Market Report Global Hepatitis Drugs market | Page 3
The major drivers of the hepatitis drugs market include the second generation DAAs of Olysio and Sovaldi
The HCV drugs segment comprised more than 84 % of the total market share in 2016.
Currently, the market players are developing IFN therapies for the treatment of Hepatitis C.
Market Overview
The major drivers of the hepatitis drugs market include the second generation DAAs of Olysio and Sovaldi
The HCV drugs segment comprised more than 84 % of the total market share in 2016.
Currently, the market players are developing IFN therapies for the treatment of Hepatitis C.